In 2017 BAYER identified the need to change crop protection through innovative technologies. Together with The Trendlines Group, Israel’s leading agrifood tech investor, they established the Bayer Trendlines Ag Innovation Fund, which founded our company.
We use natural Single Domain Antibodies or SDAs as our novel active ingredients, combined with a new mode of action, we are creating a new class of Bioinsecticides.
Shir Baor
[email protected]
https://www.ibi-ag.com/
WHAT SETS US APART?
This new technology, applied to crops with standard spaying, holds many game-changing advantages:
- The Active ingredient is highly effective due to high affinity for target protein
- The SDAs affects only the target insect, making them perfectly safe for beneficial insects, the environment, and for us.
- Unlike conventional antibodies, they are stable and active in field conditions and can survive the sun’s UV light.
- They are faster and cheaper to produce making them cost-effective.
- This new technology enables us to significantly shorten the development time and cost of our products, and to create a fast-growing platform of effective products.
WHERE WE ARE?
We are now focusing on optimizing our first product for greenhouse trials.
In parallel, we’re exploring the early effects on additional pests from new families with most promising results.
WHERE WE ARE GOING?
Our vision is to change the crop protection market by providing viable alternatives to conventional chemical pesticides.
We invite you to join us in this critical mission of providing the world with sustainable food supply, protecting our planet and its resources, and reaping the rewards.